Dr. Michael Andrew Register, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3689 Wilma Edwards Rd, Ellabell, GA 31308 Phone: 912-653-4357 Fax: 912-653-4320 |
News Archive
Small and stand-alone nonprofit hospitals are facing mounting pressure from weak operating margins and lower patient volumes, according to a report from Standard & Poor's Rating Services. Meanwhile, hospitals cope with the changing health care landscape by exploring ways to help low-income consumers pay their Obamacare premiums and offering no-interest payment plans for those with high-deductible insurance policies.
BioClinica™, Inc.,, a global provider of clinical trial management services, is the first clinical technology provider to offer a reporting solution that incorporates the industry-standard performance metrics for clinical trials as defined by the Metrics Champion Consortium (MCC).
Depomed, Inc. today announced that its licensee has submitted a New Drug Application (NDA) for DM-1796 to the U.S. Food and Drug Administration (FDA) for the management of postherpetic neuralgia (PHN), or pain after shingles. DM-1796 is an investigational, extended release, once-daily tablet formulation of gabapentin designed to reduce dosing frequency and have a low incidence of side effects.
Pharmaceutical Institute, a leading provider of specialized training solutions for the pharmaceutical and biotech industry and a subsidiary of Campbell Alliance, today announced the release of Therapeutic Area Essentials™, a comprehensive suite of more than 155 therapeutic area e-courses covering diagnosis, cause, and treatment for over 40 disease states.
The team has developed a novel means of testing for pancreatic cancer that will enable doctors to treat the killer disease at its earliest stages. They are also now able to show how the risk of cancer for these patients changes with age.
› Verified 8 days ago